Stocks
Intellia Therapeutics (NTLA) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -35.3 | 0.00 | 0.00 | -3.25 | -2.75 | -5.11 | |||
| Changes by years, y/y, % | -38% | -100% | -15% | -45.5% | |||||
Intellia Therapeutics. P/FCF
Intellia Therapeutics. P/FCF, changes, %
Intellia Therapeutics (NTLA) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| P/FCF | -2.31 | -4.61 | -2.46 | -4.18 | -4.85 | -5.11 | ||
| Changes by years, y/y, % | -19% | -27% | +116% | +110% | ||||
| Changes by quarters, q/q, % | +19% | +100% | -47% | +70% | +16% | |||
